IBK starts coverage with KRW 30,000 target for Dongkook stock

Published on 10/06/2026 at 07:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IBK targets KRW 30,000 and sees second-half revenue at KRW 547.5 billion. For Dongkook stock, first-half operating profit was KRW 53.4 billion.

Dongkook, KR7086450004, Illustration mit AI erstellt.

IBK Investment & Securities began coverage of DongKook Pharmaceutical (ISIN KR7086450004) with a Buy rating and a KRW 30,000 target on October 2, 2026, according to EDAILY. The report puts cosmetics-led healthcare at the center of the growth case, while Dongkook's listing identity and ticker 086450 are also identified by Eulerpool.

IBK sees faster second-half growth

Seoul Economic Daily reported on October 2, 2026, that IBK projects consolidated second-half 2026 revenue of KRW 547.5 billion, up 16.60 percent from a year earlier. Operating profit is projected at KRW 60.1 billion, a 22.50 percent increase, with healthcare revenue expected to reach KRW 213.2 billion, up 34.30 percent.

The forecast compares with Dongkook's first-half 2026 revenue of KRW 509.9 billion and operating profit of KRW 53.4 billion, figures reported in the same October 2 coverage. IBK expects healthcare, including cosmetics, to contribute 39.30 percent of full-year revenue in 2026, up from 31.90 percent in 2023.

Cosmetics exports drive the thesis

LS Securities maintained a Buy rating and a KRW 30,000 target in a report dated October 1, 2026, as Seoul Economic Daily reported. The brokerage estimates 2026 cosmetics revenue at KRW 315.0 billion, up 41.40 percent year over year, and projects KRW 397.2 billion in 2027.

The export figures explain why the analyst case differs from a simple pharmaceutical growth story. Dongkook's cosmetics exports reached KRW 30.0 billion in 2025, compared with KRW 16.3 billion in 2024, and LS Securities expects KRW 120.0 billion to KRW 140.0 billion in 2026. The report also points to overseas distribution in the United States, Japan and China as a profitability driver from 2027.

KOSDAQ value and annual range

Dongkook's KOSDAQ quote was KRW 21,550 at 2:19 p.m. KST on October 6, 2026, down 5.27 percent from KRW 22,750. Its market capitalization was KRW 972.1 billion, while the 52-week range was KRW 16,260 to KRW 31,250 on the same date.